A detailed history of Cva Family Office, LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Cva Family Office, LLC holds 477 shares of ILMN stock, worth $64,881. This represents 0.01% of its overall portfolio holdings.

Number of Shares
477
Previous 478 0.21%
Holding current value
$64,881
Previous $49,000 26.53%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$105.28 - $135.9 $105 - $135
-1 Reduced 0.21%
477 $62,000
Q2 2024

Jul 09, 2024

BUY
$101.05 - $133.57 $7,881 - $10,418
78 Added 19.5%
478 $49,000
Q1 2024

Apr 10, 2024

SELL
$127.73 - $147.2 $19,798 - $22,816
-155 Reduced 27.93%
400 $54,000
Q4 2023

Jan 16, 2024

BUY
$92.79 - $142.53 $51,498 - $79,104
555 New
555 $77,000
Q2 2023

Jul 10, 2023

BUY
$183.43 - $232.67 $8,254 - $10,470
45 Added 15.52%
335 $62,000
Q1 2023

Apr 26, 2023

SELL
$193.75 - $232.55 $3,875 - $4,651
-20 Reduced 6.45%
290 $67,000
Q4 2022

Feb 21, 2023

BUY
$187.24 - $242.74 $1,872 - $2,427
10 Added 3.33%
310 $62,000
Q3 2022

Nov 22, 2022

BUY
$177.23 - $227.44 $18,609 - $23,881
105 Added 53.85%
300 $57,000
Q1 2022

Apr 22, 2022

BUY
$303.87 - $423.8 $36,464 - $50,856
120 Added 160.0%
195 $68,000
Q4 2021

Jan 25, 2022

SELL
$347.28 - $421.83 $26,045 - $31,637
-75 Reduced 50.0%
75 $29,000
Q3 2021

Oct 12, 2021

BUY
$405.61 - $524.84 $4,056 - $5,248
10 Added 7.14%
150 $46,000
Q2 2021

Jul 13, 2021

BUY
$372.84 - $481.5 $22,370 - $28,890
60 Added 75.0%
140 $66,000
Q1 2021

Apr 14, 2021

BUY
$361.28 - $504.76 $28,902 - $40,380
80 New
80 $31,000
Q4 2020

Jan 15, 2021

SELL
$292.7 - $370.96 $43,905 - $55,644
-150 Closed
0 $0
Q1 2020

May 28, 2020

BUY
$209.2 - $335.53 $31,380 - $50,329
150 New
150 $41,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.4B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Cva Family Office, LLC Portfolio

Follow Cva Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cva Family Office, LLC with notifications on news.